Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
10/2021 ceased to operate
Mydimed
Mydimed Overview
Mydimed develops algorithms and software tools designed to help prevent adverse drug reactions (ADR) among high-risk, poly-pharmacy patients. The company utilizes artificial intelligence and proprietary algorithms that derive insights from medical records and help predict and prevent morbidity and mortality.
Mydimed's technology is based on medical research and advanced data science, a powerful combination that yields better prediction results by analyzing electronic medical records and derivatives of electronic medical records to obtain an optimal approximation for the prediction of high-risk ADRs that can lead to hospitalization or readmission.